A phase II study to determine the efficacy and safety of lipoplatin and gemcitabine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

Trial Profile

A phase II study to determine the efficacy and safety of lipoplatin and gemcitabine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jan 2017

At a glance

  • Drugs Cisplatin (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top